Live Quote · NASDAQBCRXHealthcare· Biotechnology

BioCryst Pharmaceuticals, Inc.

$7.22▼ 1.37%($-0.10)
MKT CAP $1.86BNEXT EARNINGS Feb 25, 2027
50%
Bullish
TickerSpark Score
63/100
▌ Mixed
93
Valuation
50
Profitability
100
Growth
44
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BCRX research report →

Analyst Price Target
$19.00+163.2% vs. today

Range $11 – $29

Analyst RatingBuy
23 Buy6 Hold0 Sell

Price Chart

+2.70% · this period
$11.11$8.68$6.24Nov 20May 26Nov 20
52-Week Range20% of range
Low
$6.23
Current
$7.22
High
$11.22